Cahill Represents Initial Purchasers in Financing for Acquisition of TGG Medical Solutions, Inc. by Mallinckrodt plc
Date: 09/24/15
Cahill represented the joint book-running managers and the co-managers in connection with the Rule 144A offering of $750,000,000 aggregate principal amount of 5.625% Senior Notes due 2023 by Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC. Proceeds from the offering were used in connection with Mallinckrodt plc’s pending acquisition of all of the capital stock of TGG Medical Solutions, Inc., parent company of Therakos, Inc., a maker of immunotherapy treatment devices.